Literature DB >> 7538849

NMR structure determination of tick anticoagulant peptide (TAP).

M S Lim-Wilby1, K Hallenga, M de Maeyer, I Lasters, G P Vlasuk, T K Brunck.   

Abstract

Tick anticoagulant peptide (TAP) is a potent and selective 60-amino acid inhibitor of the serine protease Factor Xa (fXa), the penultimate enzyme in the blood coagulation cascade. The structural features of TAP responsible for its remarkable specificity for fXa are unknown, but the binding to its target appears to be unique. The elucidation of the TAP structure may facilitate our understanding of this new mode of serine protease inhibition and could provide a basis for the design of novel fXa inhibitors. Analyses of homo- and heteronuclear two-dimensional NMR spectra (total correlation spectroscopy, nuclear Overhauser effect spectroscopy [NOESY], constant time heteronuclear single quantum correlation spectroscopy [CT-HSQC], and HSQC-NOESY; 600 MHz; 1.5 mM TAP; pH 2.5) of unlabeled, 13C-labeled, and 15N-labeled TAP provided nearly complete 1H sequence-specific resonance assignments. Secondary structural elements were identified by characteristic NOE patterns and D2O amide proton-exchange experiments. A three-dimensional structure of TAP was generated from 412 NOESY-derived distance and 47 dihedral angle constraints. The structural elements of TAP are similar in some respects to those of the Kunitz serine protease inhibitor family, with which TAP shares weak sequence homology. This structure, coupled with previous kinetic and biochemical information, confirms previous suggestions that TAP has a unique mode of binding to fXa.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7538849      PMCID: PMC2143064          DOI: 10.1002/pro.5560040205

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  22 in total

1.  Site-directed analysis of the functional domains in the factor Xa inhibitor tick anticoagulant peptide: identification of two distinct regions that constitute the enzyme recognition sites.

Authors:  C T Dunwiddie; M P Neeper; E M Nutt; L Waxman; D E Smith; K J Hofmann; P K Lumma; V M Garsky; G P Vlasuk
Journal:  Biochemistry       Date:  1992-12-08       Impact factor: 3.162

2.  The Protein Data Bank: a computer-based archival file for macromolecular structures.

Authors:  F C Bernstein; T F Koetzle; G J Williams; E F Meyer; M D Brice; J R Rodgers; O Kennard; T Shimanouchi; M Tasumi
Journal:  J Mol Biol       Date:  1977-05-25       Impact factor: 5.469

3.  Tick anticoagulant peptide (TAP) is a novel inhibitor of blood coagulation factor Xa.

Authors:  L Waxman; D E Smith; K E Arcuri; G P Vlasuk
Journal:  Science       Date:  1990-05-04       Impact factor: 47.728

4.  Characterization of recombinant tick anticoagulant peptide. A highly selective inhibitor of blood coagulation factor Xa.

Authors:  M P Neeper; L Waxman; D E Smith; C A Schulman; M Sardana; R W Ellis; L W Schaffer; P K Siegl; G P Vlasuk
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

5.  X-ray crystal structure of the protease inhibitor domain of Alzheimer's amyloid beta-protein precursor.

Authors:  T R Hynes; M Randal; L A Kennedy; C Eigenbrot; A A Kossiakoff
Journal:  Biochemistry       Date:  1990-10-30       Impact factor: 3.162

6.  Tick anticoagulant peptide: kinetic analysis of the recombinant inhibitor with blood coagulation factor Xa.

Authors:  S P Jordan; L Waxman; D E Smith; G P Vlasuk
Journal:  Biochemistry       Date:  1990-12-18       Impact factor: 3.162

7.  Reaction pathway for inhibition of blood coagulation factor Xa by tick anticoagulant peptide.

Authors:  S P Jordan; S S Mao; S D Lewis; J A Shafer
Journal:  Biochemistry       Date:  1992-06-16       Impact factor: 3.162

8.  Anticoagulant effects of the selective factor XA inhibitors tick anticoagulant peptide and antistasin in the APTT assay are determined by the relative rate of prothrombinase inhibition.

Authors:  C T Dunwiddie; D E Smith; E M Nutt; G P Vlasuk
Journal:  Thromb Res       Date:  1991-12-15       Impact factor: 3.944

9.  The amino acid sequence of antistasin. A potent inhibitor of factor Xa reveals a repeated internal structure.

Authors:  E Nutt; T Gasic; J Rodkey; G J Gasic; J W Jacobs; P A Friedman; E Simpson
Journal:  J Biol Chem       Date:  1988-07-25       Impact factor: 5.157

10.  Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.

Authors:  T C Wun; K K Kretzmer; T J Girard; J P Miletich; G J Broze
Journal:  J Biol Chem       Date:  1988-05-05       Impact factor: 5.157

View more
  7 in total

1.  Conformational isomers of denatured and unfolded proteins: methods of production and applications.

Authors:  Jui-Yoa Chang
Journal:  Protein J       Date:  2009-01       Impact factor: 2.371

2.  Pathway of oxidative folding of a 3-disulfide alpha-lactalbumin may resemble either BPTI model or hirudin model.

Authors:  Silvia Salamanca; Jui-Yoa Chang
Journal:  Protein J       Date:  2006-06       Impact factor: 2.371

3.  The ornithodorin-thrombin crystal structure, a key to the TAP enigma?

Authors:  A van de Locht; M T Stubbs; W Bode; T Friedrich; C Bollschweiler; W Höffken; R Huber
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

4.  A novel B-domain O-glycoPEGylated FVIII (N8-GP) demonstrates full efficacy and prolonged effect in hemophilic mice models.

Authors:  Henning R Stennicke; Marianne Kjalke; Ditte M Karpf; Kristoffer W Balling; Peter B Johansen; Torben Elm; Kristine Øvlisen; Flemming Möller; Heidi L Holmberg; Charlotte N Gudme; Egon Persson; Ida Hilden; Hermann Pelzer; Henrik Rahbek-Nielsen; Christina Jespersgaard; Are Bogsnes; Anette A Pedersen; Anne K Kristensen; Bernd Peschke; Wendy Kappers; Frederik Rode; Lars Thim; Mikael Tranholm; Mirella Ezban; Eva H N Olsen; Søren E Bjørn
Journal:  Blood       Date:  2013-01-18       Impact factor: 22.113

5.  Structure of tick anticoagulant peptide at 1.6 A resolution complexed with bovine pancreatic trypsin inhibitor.

Authors:  R St Charles; K Padmanabhan; R V Arni; K P Padmanabhan; A Tulinsky
Journal:  Protein Sci       Date:  2000-02       Impact factor: 6.725

6.  Arachnids of medical importance in Brazil: main active compounds present in scorpion and spider venoms and tick saliva.

Authors:  Francielle A Cordeiro; Fernanda G Amorim; Fernando A P Anjolette; Eliane C Arantes
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2015-08-13

Review 7.  A Kunitz-type inhibitor from tick salivary glands: A promising novel antitumor drug candidate.

Authors:  Aline R M Lobba; Miryam Paola Alvarez-Flores; Melissa Regina Fessel; Marcus Vinicius Buri; Douglas S Oliveira; Renata N Gomes; Priscila S Cunegundes; Carlos DeOcesano-Pereira; Victor D Cinel; Ana M Chudzinski-Tavassi
Journal:  Front Mol Biosci       Date:  2022-08-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.